Marimed Inc (OTCMKTS
A deeper analysis of the companies and market fundamentals is perhaps one of the best ways to determine which of these cannabis stocks takes the cake. MRMD stock nearly tripled in the last 12 months and so did ORHOF, meaning both took advantage of growth opportunities available in the market.
MRMD stock gained traction in the market in 2018 by filling the consultancy services niche in the cannabis industry. It has been advising cannabis stocks on matters related to running medical cannabis production and cultivation facilities.
It has also acquired some of its clients along the way and now operates in six states and expansion continues.
The company recently revealed that it plans to launch a subsidiary company called MariMed Hemp whose main focus will be hemp products. This comes just months after the legalization of Hemp towards the end of 2018, thus opening up more opportunities. MariMed expects the focus on hemp to contribute towards generating more value for MRMD stock.
Shares of Marimed are up a whopping 30% in
Find out when $MRMD Right Now by entering your Email in the box below.
Origin House’s corner
ORHOF’s main strategy revolves around a strong presence in California which is currently considered the largest cannabis market in the world, especially for legal recreational cannabis use.
Origin House distributes cannabis products to 70% of the cannabis retail dispensaries in California.
It covers more than 50 cannabis brands and it has also been working on boosting its own brands. Origin House is also working towards expanding its successful business strategy in other markets outside California in the hopes of growing more of its business and generating more revenue.
MRMD stock might not be as ideal a pick for now as its counterpart ORHOF because the fundamentals indicate that it has a lower market cap than MariMed. Additionally, ORHOF had twice the revenue that MRMD generated in the last quarter.
Sign-up for continuing coverage on shares of these stocks, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in either Co., either long or short, and we have not been compensated for this article.